Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Short-term Investments (2016 - 2025)

IGC Pharma (IGC) has disclosed Short-term Investments for 11 consecutive years, with $25000.0 as the latest value for Q3 2025.

  • Quarterly Short-term Investments changed N/A to $25000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $25000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $154000.0 for FY2023, N/A changed from the prior year.
  • Short-term Investments for Q3 2025 was $25000.0 at IGC Pharma, down from $98000.0 in the prior quarter.
  • The five-year high for Short-term Investments was $227000.0 in Q2 2023, with the low at $25000.0 in Q3 2025.
  • Average Short-term Investments over 4 years is $123571.4, with a median of $98000.0 recorded in 2023.
  • Peak annual rise in Short-term Investments hit 49.22% in 2023, while the deepest fall reached 49.22% in 2023.
  • Over 4 years, Short-term Investments stood at $80000.0 in 2021, then grew by 10.0% to $88000.0 in 2022, then rose by 11.36% to $98000.0 in 2023, then plummeted by 74.49% to $25000.0 in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $25000.0, $98000.0, and $227000.0 for Q3 2025, Q3 2023, and Q2 2023 respectively.